Sesame Summit 2026 – application open

10 Medtech Startups to watch in 2021 – Selected

The global medtech market was projected to reach US$ 481.2 billion in 2020. Continuing it’s growth at a CAGR of 5.2% during 2021-2026 it is projected to reach US$ 652.3 billion by 2026.

The largest medtech market is North America with a market share of around 43% in 2018.

Europe follows in second place and makes up 27% of the world market. The biggest markets in Europe are Germany, France, the United Kingdom, Italy and Spain.

Here are 10 Medtech Startups to Watch in 2021.


Lalibela Global-Networks

Country: Ethiopia

Year: 2016

Funding Stage: (Information unavailable)

Investors: (Information unavailable)

Description: Lalibela Global-Networks aims to lead the digital transformation of the health sector in Africa. The startup offers healthcare software, including a digital health record system: ABAY-CHR to automate hospital management and reduce day-to-day stationery resources.

Streamlining administrative tasks and reducing time spent finding patient files, Lalibela Global-Networks improves the functionality of medical centers while making healthcare more affordable for patients.

Highlight: Lalibela Global-Networks was the winner of Web Summit’s PITCH startup competition 2020.


XUND

Country: Austria

Year: 2018

Funding Stage: Seed

Investors: TBA Tyrolean Business Angel

Description: XUND is a Vienna based digital health startup developing an AI-powered health assistant designed to improve the quality and accessibility of healthcare. By providing a digital interface between users and the healthcare system, XUND aims to save time, costs and increase the quality of life.

Highlight: PITCH quarter-finalist at Web Summit 2020


Smart Diagnosis

Country: South Korea

Year: 2018

Funding Stage: Early-Stage

Investors: (Information unavailable)

Description: Smart Diagnosis has developed a vital signs extraction algorithm that can analyse the human eye using a smartphone camera for a full patient health assessment.

The Smart Diagnosis app will be accessible on any mobile device anywhere in the world and will also be integrable with other digital healthcare systems.

Highlight: PITCH quarter-finalist at Web Summit 2020


Geneonbiotech

Country: South Korea

Year: (Information unavailable)

Funding Stage: Early-Stage

Investors: (Information unavailable)

Description: Geneonbiotech offers a simple, non-invasive Covid-19 diagnostic solution that greatly reduces time taken to produce a result.

Users provide a saliva sample, rather than a nasal scraping, and are given a result within 45 minutes. Test results are 99 percent accurate, and the system can be used by non-experts.

Geneonbiotech’s testing platform also incorporates a telemedicine communication service to help improve diagnostics and user care.

Highlight: PITCH quarter-finalist at Web Summit 2020


AiDx Medical

Country: Netherlands

Year: 2019

Funding Stage: Pre-Seed

Investors: EIT Health Headstart Fund

Description: AiDx technology brings an affordable alternative to standard microscopic examination by optimally addressing all components of the diagnostic cycle.

Highlight: Winner of Digital Health & Medical Devices category at Hello Tomorrow Summit 2020


TeleMedC

Country: Singapore

Year: 2014

Funding Stage: Early-Stage

Investors: (Information unavailable)

Description: TeleMedC is a diagnostic imaging solutions company using sophisticated retinal imaging.

Their primary objective is to provide low cost diagnostic solutions for point-of-care screening and virtual management of eye and chronic diseases throughout the world.

Highlight: Finalist in Digital Health & Medical Devices at Hello Tomorrow Summit 2020 & ‘Most Investable Startup’ award at Slingshot – Startup Competition of SWITCH 2020


Vibrosonic GmbH

Country: Germany

Year: 2016

Funding Stage: Grant Funding

Investors: EASME – EU Executive Agency for SMEs

Description: Vibrosonic has developed a hearing contact lens which is designed to mimic the natural hearing process to a large extent and thus significantly improve the sound experience of hearing impaired people.

Highlight: Finalist in Digital Health & Medical Devices at Hello Tomorrow Summit 2020 & Spin-off of from the Fraunhofer Project Group


Cirqle Biomedical

Country: Denmark

Year: 2018

Funding Stage: Pre-Seed

Investors: BioInnovation Institute & Rhia Ventures

Description: Circle Devices develops a next generation contraceptive product, which aims to create a natural, desirable and safe alternative to existing contraceptive products.

Highlight: Finalists in Digital Health & Medical Devices at Hello Tomorrow Summit 2020


Nanosynex

Country: Israel

Year: 2017

Funding Stage: Grant Funding

Investors: EASME – EU Executive Agency for SMEs & MassChallenge

Description: Nanosynex is developing a diagnostic test that can check bacterial resistance to antibiotics in a record time using microfluidics techniques, based on a revolutionary scientific development from the Technion.

The test will help doctors determine the most appropriate antibiotic treatment for patients and provide same day results. Same day results will help reduce the spread of resistant bacteria in an environment and significantly lower the burden on healthcare costs.

Highlight: Finalists in Digital Health & Medical Devices at Hello Tomorrow Summit 2020


Cellsway

Country: UK & Turkey

Year: 2020

Funding Stage: Pre-Seed

Investors: (Information unavailable)

Description: Cellsway focuses on the development of microfludics and lab-on-a-chip systems for biomedical applications.

The core product of the company is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research.

The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells from the blood samples of cancer patients.

Highlight: Finalists in Digital Health & Medical Devices at Hello Tomorrow Summit 2020


Medicsen

Country: Spain

Year: 2015

Funding Stage: Seed

Investors: dotforge, TURN8, Vertical.vc, EASME – EU Executive Agency for SMEs & Hot DesQ

Description: MedicSen’s aim is to launch a treatment that will change the way we deal with diabetes forever.

They have created an application capable of integrating information from continuous glucose meters with other parameters introduced by the user or collected by intelligent devices. The end results offers users a record of their glycemic values and provides a reliable prediction of future values.

MedicSen uses an innovative learning algorithm that communicates with the user through a chat-bot type interface.

Highlight: Winner of Pitch Competition at EU-Startups Summit 2018 & Track Winner of ‘Health & Wellbeing’ at South Summit Competition 2020


If you’ve found this report valuable and if you’re a corporate or investor looking for innovative startups within a specific market, please get in touch.

you might also like

Fundraising 4 hours ago

The European property technology sector is experiencing unprecedented growth, driven by digitisation demands from homeowners managing shared properties. Berlin-based Dotega has secured €13 million in funding to expand its proptech platform that enables homeowner self-management of shared residential properties across European markets. The round positions Dotega to capitalise on the fragmented European property management market, where traditional solutions often fail to address the specific needs of shared ownership structures prevalent across Germany, Austria, and Switzerland. High-Tech Gründerfonds leads proptech funding round High-Tech Gründerfonds, Germany’s seed investor with a strong track record in proptech ventures, led the €13 million round. The investor’s thesis centres on the significant digitalisation gap in European property management, particularly for shared ownership scenarios that require sophisticated coordination tools. “Dotega addresses a genuine pain point in the European property market where homeowners struggle with the complexity of managing shared properties,” said a representative from High-Tech Gründerfonds. “Their platform transforms what has traditionally been a bureaucratic nightmare into a streamlined digital experience.” The funding round reflects growing investor confidence in European proptech solutions that tackle region-specific challenges, particularly around shared ownership models that differ significantly from Anglo-Saxon property structures. Platform targets European shared property management gap Dotega’s platform specifically addresses the complexities of managing properties with multiple owners, a common scenario in German-speaking markets where shared ownership structures are deeply embedded in property law. The solution provides tools for expense tracking, maintenance coordination, and decision-making processes that traditionally required expensive property management services. The company plans to use the €13 million to expand beyond its core German market into Austria and Switzerland, where similar regulatory frameworks and ownership structures create natural expansion opportunities. Dotega’s European-first approach recognises that property management solutions cannot simply be transplanted from other markets due to varying legal and cultural contexts. “We’re building for European property owners who need solutions that understand local regulations and ownership structures,” noted Dotega’s leadership. “Our platform isn’t just translated software – it’s built from the ground up for European property law and customs.” This funding signals the maturation of European proptech beyond simple rental platforms towards sophisticated solutions for property ownership complexity. Dotega’s focus on shared ownership management could establish a blueprint for addressing similar challenges across Europe’s diverse property markets.

Fundraising 3 days ago

European impact investing is gaining unprecedented momentum as institutional capital increasingly demands measurable social and environmental returns alongside financial performance. This shift has created fertile ground for specialised funds that can navigate the complex intersection of profit and purpose, particularly as EU regulations like the Sustainable Finance Disclosure Regulation reshape the investment landscape. Rubio Impact Ventures has successfully closed its third fund at €70 million, reinforcing its distinctive approach of tying 100% of investments to measurable impact outcomes. The Madrid-based venture capital firm has established itself as a leading voice in European impact investing, demonstrating that rigorous impact measurement and strong financial returns need not be mutually exclusive. Impact investing fund closure signals sector maturation The successful closure of Rubio’s third fund reflects growing investor appetite for impact-focused strategies across Europe. Unlike traditional ESG approaches that often apply impact considerations as an overlay, Rubio’s methodology embeds impact measurement into every investment decision from day one. This comprehensive approach resonates particularly well with European institutional investors who face increasing regulatory pressure to demonstrate genuine sustainability credentials. The fund’s investor base comprises a mix of family offices, institutional investors, and impact-focused limited partners across Europe, highlighting the broadening appeal of impact investing beyond traditional philanthropic circles. Rubio’s track record of delivering both measurable impact and competitive financial returns has enabled it to attract capital from investors who previously viewed impact investing as requiring financial trade-offs. “Our third fund represents not just capital, but a mandate to prove that impact and returns are complementary forces,” explains the fund’s investment team. “European startups are uniquely positioned to lead global impact innovation, particularly in areas where regulatory frameworks create competitive advantages.” European impact startups attract focused capital Rubio’s investment thesis centres on European startups addressing sustainability challenges through technology-driven solutions. The firm’s portfolio spans sectors including clean technology, circular economy, social impact, and sustainable agriculture—areas where European companies often benefit from supportive regulatory environments and sophisticated consumer demand for sustainable alternatives. The €70 million fund size positions Rubio to lead Series A and B rounds for European impact startups, a critical funding gap in the market. Many impact-focused companies struggle to scale beyond seed funding, as traditional venture capital firms often lack the specialised expertise to evaluate impact metrics alongside financial projections. Rubio’s dedicated approach addresses this market inefficiency directly. The fund’s 100% impact-tied investment approach requires portfolio companies to establish clear, measurable impact objectives that align with UN Sustainable Development Goals. This methodology provides both entrepreneurs and investors with concrete frameworks for tracking progress beyond traditional financial metrics, creating accountability structures that drive genuine impact outcomes. This successful fund closure signals growing maturation within European impact investing, where specialised capital increasingly flows to startups that can demonstrate both scalable business models and measurable positive impact. As European markets continue prioritising sustainability across all sectors, focused impact funds like Rubio’s third vehicle are becoming essential infrastructure for the continent’s transition to a more sustainable economy.

Fundraising 3 days ago

Impact measurement in European business is shifting from optional add-on to strategic necessity. As sustainability regulations tighten across the EU and stakeholder capitalism gains momentum, startups building the infrastructure for measurable impact are attracting serious attention. Contribe exemplifies this trend, having just secured €1.3 million in pre-seed funding to accelerate its impact measurement platform across European markets. The funding round positions Contribe at the intersection of two powerful European movements: the regulatory push for transparent impact reporting and the growing demand from investors for quantifiable sustainability metrics. Pre-seed funding round attracts impact-focused investors While the specific investors in Contribe’s €1.3 million pre-seed round remain undisclosed, the funding reflects a broader European appetite for impact measurement solutions. European VCs are increasingly prioritising startups that can quantify and optimise social and environmental outcomes, particularly as EU regulations like the Corporate Sustainability Reporting Directive (CSRD) create compliance requirements. The pre-seed timing suggests Contribe is positioning itself ahead of the regulatory curve. With CSRD requirements rolling out progressively through 2026, companies across Europe will need robust impact measurement systems. This regulatory tailwind creates a compelling investment thesis for early-stage funds focused on regulatory technology and sustainability infrastructure. Impact-focused investors are drawn to platforms that can standardise measurement across diverse sectors and geographies – a particular challenge in Europe’s fragmented market landscape. The funding will likely support Contribe’s efforts to build scalable measurement frameworks that work across different European regulatory environments. Impact platform targets European compliance landscape Contribe’s platform addresses a critical gap in European impact measurement infrastructure. While traditional metrics focus on financial returns, Contribe enables organisations to quantify social and environmental outcomes using standardised methodologies. This capability becomes increasingly valuable as European businesses face mounting pressure to demonstrate measurable impact alongside profitability. The platform’s approach aligns with European preferences for collaborative, stakeholder-driven business models rather than purely profit-maximising approaches. By providing transparent measurement tools, Contribe supports the broader European vision of sustainable capitalism that balances multiple bottom lines. The €1.3 million funding will likely focus on product development and market expansion across key European markets. Given the diverse regulatory requirements across EU member states, Contribe must build flexibility into its platform while maintaining standardisation – a complex technical and commercial challenge that could determine its competitive position. European organisations increasingly require impact measurement solutions that integrate with existing business processes rather than operating as standalone systems. This integration challenge represents both an opportunity and a technical hurdle for platforms like Contribe. The pre-seed funding signals confidence in Contribe’s ability to navigate Europe’s complex impact measurement landscape. As regulatory requirements intensify and stakeholder expectations evolve, platforms that can deliver accurate, standardised impact measurement will become essential infrastructure for European business.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.